Advocacy intelligence hub — real-time data for patient organizations
Onchilles Pharma Inc — PHASE1, PHASE2
OHSU Knight Cancer Institute — PHASE2
Essen Biotech — PHASE1, PHASE2
Molecular Partners AG — PHASE1, PHASE2
Xynomic Pharmaceuticals, Inc. — PHASE1, PHASE2
Pfizer — PHASE1
Hansoh BioMedical R&D Company — PHASE1
Elephas
Innate Pharma — PHASE1
Vall d'Hebron Institute of Oncology — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Matthew Krebs, Dr
The Christie Hospital
Global Clinical Leader
Daiichi Sankyo
Andrea B Apolo, M.D., MD
National Cancer Institute (NCI)
📍 BETHESDA, MD
Study Official
Genmab
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Joe Y Chang
M.D. Anderson Cancer Center